Introduction
The increasing incidence of dementia with the change in the world age demographic is a source of major public health concern. Early and accurate identification of individuals at high risk of dementia has become a research priority, especially with the promise of future preventative strategies to limit the expected rise of chronic neurodegenerative diseases consequent to an increased life span of the populations both in developed and developing countries. In the last decade identification of high risk cases has focused on the concept of Mild Cognitive Impairment (MCI), defined as an intermediate state between normal cognitive ageing and dementia. Numerous definitions for this state have been proposed, generally divided into those terms that capture normal age related cognitive change and those that capture pathological decline(1). The latter are a focus of research attention with the aim of identifying individuals at high risk of future dementia(2). However, it is not clear to what extent criteria for MCI discriminate those who will develop dementia when applied in population based samples.
While useful as an opportunity for early dementia risk screening in clinical samples, MCI as currently conceptualised does not appear to transfer well to the population setting. Studies of dementia incidence in MCI cohorts report up to 40-70% of cases remaining stable or reverting to normal cognitive function over time (3) (4) (5) (6) , with rates of progression generally depending on operationalisation of MCI criteria including: severity of cognitive impairment (e.g., 1, 1.5 or 2 standard deviations (SD) below the mean), underlying neuropsychological deficit (e.g., amnestic, non-amnestic and multi-domain subtypes) and psychometric test choice(5, 7-12).
Additionally, many individuals who develop dementia at follow-up are found to have had a level of impairment outside the MCI range at baseline, and were therefore excluded from an MCI case diagnosis (here called non-classified or NON-C cases)(13). This finding raises the question of whether a risk threshold derived from a combination of the MCI and NON-C groups improves dementia risk prediction in the general population. 4 Here we compare risk thresholds derived from six commonly used MCI case definitions as well as the Mini Mental State Examination (MMSE)(14) with respect to their ability to discriminate those at risk of incident dementia in the older population. Using data from the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) we stratified all non-demented individuals into three risk categories, including low, moderate and high based on dementia incidence for the normal, MCI and NON-C groups previously reported for each MCI definition(5, 13). We then compared two-year dementia incidence across different combinations of the three risk categories to assess the current potential use of each as a screening tool for predicting dementia risk.
Methods

Study Design and Subjects
MRC CFAS is a large multi-centre population based prospective cohort study of individuals aged 65 years and older from the UK. Full details of the study design and procedures are published elsewhere and are briefly described here(15) (http://www.cfas.ac.uk). Individuals were randomly selected from the Family Health Service Authority lists in five areas in England and Wales including two rural (Cambridgeshire and Gwynedd) and three urban (Newcastle, Nottingham and Oxford) . Baseline interviews were undertaken from 1991-1992.
A two-phase screening procedure was used. At baseline screening, 13,004 individuals provided information on physical, behavioural and sociodemographic status in addition to aspects of health including self reported chronic conditions, and cognition using the MMSE.
Individuals also completed selected items from the Geriatric Mental State (GMS)
Examination(16). The GMS is a standardised psychiatric interview designed to detect dementia, depression, and other psychiatric illness in people aged 65 years and older by use of an algorithmic programme called the AGECAT (Automated Geriatric Examination Computer 5 Assisted Taxonomy)(16). Following the baseline interview a sub-sample of approximately 20% (n=2,640) were selected based on age, centre and cognitive ability, and weighted toward the cognitively frail to participate in a more detailed assessment interview. This included full mood and organicity sections of the GMS in addition to more detailed cognitive assessment using the Cambridge Cognitive Examination (CAMCOG)(17). Information on medical conditions, health status and functional ability were also collected. Respondents who underwent further assessment were asked to complete one or two yearly follow-ups(15). Data from the initial prevalence screen, first assessment and two year follow-up interviews (Data Version 8.2, December 2006) were used in this analysis, in addition to death notifications from the UK National Health Service Central Register.
Diagnosis of Dementia, Depression and Anxiety
The study diagnosis of dementia is based on the GMS AGECAT algorithm, defined as an organicity scale rating of 3 or above. This is comparable to dementia as diagnosed by the DSM-III-R(18-19). Using relevant GMS symptom items depression and anxiety were both defined as an AGECAT symptom level of 3 or above.
Cognitive Assessment
General cognitive function was assessed using the MMSE. In those definitions that required "normal general cognitive function" a MMSE score of 21 or less was used to indicate impairment(20-21). Memory and non-memory cognitive performance was evaluated using the subscales of the CAMCOG including: orientation, language, memory (learning, recent, and remote), attention and calculation, praxis, abstract thinking, and perception. Currently there is no consensus on the severity level (e.g., 1SD, 1.5SDs or 2SDs below the mean) for operationalising the MCI criterion of "objective cognitive impairment" (3, 8, (22) (23) . As such, memory impairment was defined using a cut-off score of 1SD below the mean (estimated using the 16 th percentile as subscale scores are not normally distributed), on any of the three 6 CAMCOG memory sub-tests including learning memory, recent memory and remote memory. Impaired memory could therefore be in a single or multiple memory domains.
Normal memory performance was defined as a score above the -1SD cut-off value on all three memory sub-tests. Non-memory impairment was also defined using a cut-off score of 1SD below the mean (16 th percentile), on one or more of the following subscales including:
orientation, language, attention/calculation, praxis, abstract thinking or perception. Normal non-memory performance was defined as a score above the -1SD cut-off value on all nonmemory subscales. In addition, memory and non-memory impairment was defined using a stricter severity level of 1.5SDs below the mean, estimated using the 7 th percentile. For Mayo
Clinic defined MCI(24-25), severity scores were age standardised using five year age groups.
Memory Complaint
Memory complaint could be reported by the individual or their informant. A combined score was created from three questions including: (1) Have you had any difficulty with your memory?; (2) Have you tended to forget things recently?; and, (3) Has he/she had any difficulty with his/her memory? Answers for each question were coded into two categories (yes or no), from which individuals were dichotomized into non-complainers or complainers (positive response to one or more questions).
Functional Disability: Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL)
Functional disability was assessed using questions from the Modified Townsend Disability For this analysis those individuals in Group 3 (impaired BADLs) were excluded at baseline.
As such, mild IADL deficits were not an exclusion for MCI, similar to the Cardiovascular Health Study Cognition Study(27).
Exclusion Criteria
Definitions of MCI typically exclude individuals with psychiatric and vascular co-morbidity to help improve diagnostic accuracy(2). Individuals with anxiety or depression, or self reported history of stroke, heart attack, Parkinson's disease or severe functional difficulty (defined above) were therefore excluded from MCI mapping. Of the 2,640 individuals at first assessment a total of 818 (31.0% back weighted to the UK population) non-demented individuals had one or more excluding conditions or missing health status information on one or more health variables and were excluded from our analysis. In addition, individuals with a diagnosis of dementia at first assessment were excluded. Of the 2,640 individuals at first assessment, 587 were diagnosed with dementia. the MMSE, scores in the range of 22-26 were used to define the MCI group based on the results of this test alone. For each definition in order to be classified into the normal group an individual had to perform within normal limits on all criteria. As such NCI groups were defined differently depending on the MCI definition. All non-demented persons who were not normal but did not fulfil all MCI diagnostic criteria, such as for example a person who satisfies all A-MCI criteria but is classified as a non-complainer, were coded as non-classified (NON-C) for each definition(13). All individuals with missing MCI criterion data were excluded when each definition was mapped. Population based prevalence estimates and the two year dementia progression rates for the NCI, MCI and NON-C groups (back-weighted to the UK population) for each definition are shown in Table 1 .
MCI Classification
Assigning Participants to Dementia Risk Categories
Three dementia risk categories were defined including low, moderate and high based on the two year dementia progression rate for the NCI, MCI and NON-C groups outlined in Table 1 .
As shown in Table 1 , across all definitions the NCI group had the lowest dementia progression rate and therefore was assigned the LR category. The high risk category included either the MCI or NON-C group depending on which had the highest dementia progression rate, as shaded in Table 1 . The remaining group was considered to be at moderate risk.
Based on the dementia risk categories each MCI definition therefore defines two thresholds for identifying at-risk individuals. The first compares the LR group to the MR and HR groups combined (Threshold 1: T1). This risk threshold represents a comparison between the NCI group to the risk defined by combining the MCI and NON-C groups. The second is the LR and MR groups combined compared to the HR group (Threshold 2: T2). Here, as defined above the high risk group for each definition is whichever of the NON-C or MCI group had the highest two year dementia progression rate (5, 13). The baseline demographic characteristics for the at-risk and not-at-risk groups defined by each risk threshold at each cognitive severity level (1SD vs. 1.5SDs below the mean) are available in Supplementary Appendix Table A .
Analysis
Diagnostic accuracy for each of the two risk thresholds across the different MCI definitions was compared using the Receiver Operating Characteristic (ROC) method, with two year dementia incidence as the outcome. The ROC curve plots the sensitivity of each classification or the proportion of dementia cases identified, against one minus its specificity, where specificity is the proportion of those not developing dementia correctly identified. A perfect model has both sensitivity and specificity of 100%, and would be plotted in the upper left corner. The prognostic power of the MMSE score was also examined continuously and the ROC curve corresponding to using each MMSE score as a risk threshold for incident dementia is also included.
To compare the groups identified as being at-risk by each risk threshold we plotted the positive predictive value (PPV) for the at-risk group against the number of people classified as being at-risk for all MCI definitions. Further, to compare the groups identified as being not-at-risk by each risk threshold we plotted the size of the subgroup classified as not-at-risk against the negative predictive value (NPV) for all MCI definitions.
Analysis was undertaken using Stata (Version 10: Stata Corporation, College Station, Texas).
Population based proportions were estimated from the sample using an inverse probability weight. This weight was applied to each individual and was the reciprocal of the probability of that individual being included in the analysis. The probability was estimated using weighted logistic regression accounting for the over-sampling in the assessment arm of older and more cognitively impaired participants and attrition (death and dropout) between baseline 11 and follow-up interviews. Binomial confidence intervals for proportions taking into account the probability weights were calculated using a Wilson score interval(33).
Results
There were 137 incident dementia cases over the two year follow-up period (population backweighted two year incidence rate=4.4%). The ROC results for each MCI definition (at both cognitive severity levels) for each risk threshold are presented in Table 2 . As expected, for each definition the severity level of -1.5SDs resulted in an improvement in specificity but with fewer dementia cases detected, i.e., lower sensitivity. All comparisons discussed below are based on the -1SD severity level. Overall, the component criteria for ARCD define the most sensitive and specific thresholds.
ROC Curve
Similar results for both risk thresholds were found due to the small number of individuals classified into the moderate risk group i.e., satisfy criteria for ARCD (Table 1: n=40, prevalence<1.5%). The MMSE provides classifications that are at least as good as, or better than most other MCI derived risk thresholds Figure 2 compares the PPV of each at-risk group with the percentage of persons identified as being at-risk (see Table 2 ) by the two risk thresholds for 12 all MCI definitions. As shown, no method was able to identify an at-risk group with a dementia risk of more than 20%, apart from the very small group with an MMSE19.
Identifying a High Risk Cohort
However this is considerably higher than the 4% risk seen in the general population. Overall, at-risk case selection was variable. For example, when using M-MCI defined thresholds, less than 5% of the sample was identified as being at-risk with approximately 20% of these individuals progressing to dementia at two years. In contrast, the thresholds defined using criteria for CIND identified approximately 45% of the sample as being at-risk, with dementia progression of 9%, roughly twice the incidence in the general population. Therefore, when used to predict at-risk cases, MCI defined risk thresholds are either very inclusive with low progression rates, or very strict with moderate progression rates. Furthermore, from the MMSE curve ( Figure 2 ) diagnostic accuracy of each MCI defined threshold was not better than using the MMSE.
Identifying a Low Risk Cohort
Each classification defines an at-risk group, and so implicitly all other cases are defined as being not-at-risk. Figure 3 compares the progression rate in the not-at-risk group by its size for each risk threshold across the different MCI definitions.
Generally the smaller the not-at-risk group identified, the lower the risk within that group.
Overall, the ARCD defined thresholds identified a large not-at-risk group (approximately 80% of individuals) with a 0.5% chance (dementia progression range 0.0-2.5%) of two year incident dementia.
Discussion
In this study we investigated a possible strategy to maximise identification of individuals at risk of dementia in a population based cohort. When applied in population based samples MCI criteria necessarily create three groups including those meeting the criteria and being defined as MCI, those defined as not impaired (NCI), and those identified as impaired but without meeting the criteria. Rather than a risk dichotomy based on a positive vs. negative 13 MCI case diagnosis, we used previously derived incident dementia rates from NCI, MCI and NON-C groups as the basis for three levels of risk stratification and then tested, for previously published MCI definitions, two different risk classification thresholds. These were compared with the discriminatory ability of the MMSE in the same cohort. We found that different definitions of MCI identified subgroups that varied with respect to their dementia risk over a two year period. Overall at-risk case selection was generally poor. In contrast, all MCI criteria accurately defined a not-at-risk threshold that captured the majority of individuals who are unlikely to develop two-year incident dementia.
With regard to at-risk case selection, for most definitions, Threshold 1 where the at-risk group was defined as the combination of the MCI and NON-C groups was better a discriminating individuals at-risk of dementia, with the exception of the definition of N-MCI. For N-MCI discrimination of at-risk from not-at risk cases was better with Threshold 2 where the not-atrisk group was defined as the combination of: (1) people who performed within normal limits on all Mayo Clinic Criteria; and, (2) people who satisfy Mayo Clinical Criteria for N-MCI (including subjective memory complaint, normal general cognitive function, no severe functional impairment, normal memory performance and impaired non-memory performance). Here, the at-risk group was defined as all people who fell outside the N-MCI range (i.e., people with single-amnestic or combined amnestic and non-amnestic impairments). As such, these results support previous findings that suggest that impaired performance in non-memory domains is not as effective at identifying individuals who progress to dementia if memory is not affected(5, 34).
While risk thresholds derived from some MCI definitions identified a small proportion of those at-risk of dementia within two years with a high prevalence of undetected cases (e.g., A-MCI), others were able to identify most people who developed incident dementia through inclusion of a very large proportion of the older population (e.g., CIND Compared to more detailed MCI definitions the MMSE was generally found to have a higher combined sensitivity/specificity, with the exception of the thresholds derived from the definition of ARCD. MMSE is easy to administer in non-clinical samples and does not require more detailed MCI criteria. However, overall the best threshold was that derived from criteria of ARCD which includes further objective memory testing in addition to the MMSE.
Whether the improvement in accuracy when using the MMSE in combination with objective memory testing is large enough to be justifiable, especially in terms of extra data collection costs will depend on the reason for screening as well as the availably of resources.
Using stricter cut-points for cognitive severity level (-1.5SD vs. -1SDs) had the effect of substantially reducing the sensitivity of definitions without sufficient corresponding 15 improvement in specificity. This is not unexpected in population based samples where the level of ability would be expected to be more variable and generally higher than in clinic based samples. Overall the results suggest that for population dementia risk screening too strict clinical criteria fail to capture all individuals at risk.
With regard to not-at-risk case selection the results suggest that the discriminatory power of the MMSE as well as several different definitions of MCI could be sufficient for identifying a large group of the older population as being at very low risk of dementia incidence. The ARCD derived thresholds were able to identify a sub-group of around 80% of individuals with normal age associated change, alive at two years follow-up and at 0.5% risk of dementia.
The remaining 20% had roughly 15% risk of two year dementia incidence and can be considered to be at greater risk. Classification of not-at-risk cases using MCI criteria therefore provides a potentially useful tool to streamline future research into better methods for the remaining groups in who staged methods or timed re-screening may be more appropriate.
There are some limitations to the study. The cognitive assessment was performed with the MMSE and CAMCOG with specific cut-off scores. Different measures and impairment severity levels will lead to varying results. However, there are currently no recommendations regarding which psychometric instrument(s) or severity level maximise screening accuracy
and this remains to be tested. In this study, MCI was mapped retrospectively using the application of standardised rules and measures and therefore does not benefit from the flexibility of clinical judgement. However, clinical judgement adds a subjective element to mapping which is not replicable and consistent rules allow for direct comparison across every MCI definition within the same sample. Dementia progression was evaluated within a two year time frame and during longer follow-up more persons would be expected to progress to dementia. However, screening would be expected to be effective over a limited time frame.
Shorter time frames of risk would be beneficial for targeted treatment, while longer time (NON-C cases). However, no objective criteria for identifying the NON-C group exist and risk in this group has not been externally validated. Given the high dementia progression rate in the NON-C group and the finding that at-risk case identification is generally improved when MCI and NON-C groups are combined, the characteristics of the NON-C group, and how best to define MCI so at-risk cases are not excluded from diagnosis must be explored.
Conclusion
If screening for MCI is to be undertaken in the population such criteria would be expected to classify people accurately into one of three groups as defined in this analysis: (1) those at high risk for referral and management/treatment, without criteria being over or under inclusive; (2) those at moderate risk in whom deficits are suspect and where a period of watchful waiting, timed re-screening or active monitoring is more clinically appropriate; and, (3) those not at increased risk (either high functioning or with non-pathological age associated decline) who can be excluded. Criteria that are too strict will cause many cases that would benefit from early diagnosis and further follow-up to be missed, while criteria that are too inclusive will 17 result in many cases inappropriately identified for intervention (such as enrolment into clinical trials). Currently, clinic based MCI criteria do not perform at the very high levels required for their application as screening tools for those at high risk of incident dementia in the general older population justifying a referral, but they are able to discriminate those at elevated risk in whom watchful waiting or a cheap low-risk intervention would be appropriate from those at very low risk. Different methods for at-risk case identification must be developed which may include the unique characteristics in each definition that clearly distinguish normal age associated change, non progressive and progressive MCI.
Identification and exclusion of not-at-risk groups may present a possible targeted strategy.
The number of persons classified as being not-at-risk is substantial, and by using an exclusion approach many individuals in whom preventative treatment would not be beneficial can be correctly excluded from clinical trials. Importantly we have shown that this is possible from a simple screening test such as the MMSE and more complex MCI criteria are not required.
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